Status:
COMPLETED
Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
Lead Sponsor:
Pfizer
Conditions:
Juvenile Idiopathic Arthritis
Eligibility:
All Genders
5-16 years
Brief Summary
This surveillance is conducted to survey the followings under the post marketed drug utilization on the patients who are administrated ENBREL as a treatment for active polyarticular JIA. 1. Primary O...
Detailed Description
All patients who administrated ENBREL for active polyarticular juvenile idiopathic arthritis during registered period (2.5 year).
Eligibility Criteria
Inclusion
- Patients in active polyarticular JIA (restricted to the case of lack of effect by other treatment) during enrollment period (2.5years).
- Patients receiving Enbrel for JIA as diagnosed by a qualified physician.
- Age 5 - 16 years
Exclusion
- Patients not administered ENBREL
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT01145352
Start Date
July 1 2009
End Date
October 1 2013
Last Update
September 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yokohama City University School of
Tokyo, Japan, Japan